Meet the Thought Leaders and companies that are building the pharmaceutical development innovations of tomorrow – Inspiration, Growth, and Opportunity await.
The Pharmaceutical Development Innovations book is a 350-page in-depth Industry Resource Guide that showcases all of the people, companies, products, and services that are leading the innovation within the industry. A book with augmented reality video, an online platform and a network with a common goal of ensuring the world’s best innovations and innovation enablers in the Pharma Services industry connect and succeed.
The target audience for this publication is aimed at pharmaceutical sponsors and decision makers seeking innovative solutions to pharmaceutical development. In addition, it is aimed at business leaders, market analysts, and investors seeking innovative growth opportunities, partners and investments. This publication is for forward-thinking professionals who want to know what and who there is to know in the ecosystem and play an active role in its growth and development.
Nominations are now open and this is your chance to help showcase the Innovators that you know, to the world! Nominate a deserving company to be featured in INNOVATIONS in Pharmaceutical Development using the button below.
Sven Boermeester is a global publishing entrepreneur with a career that spans over 20 years with stops in more than 100 countries. He was born in Antwerp, Belgium and grew up in South Africa. After completing his business studies in Cape Town, he opened his first media company and started publishing the trade and industry directories for South Africa followed by the launch of the Best of the World publishing series in Dubai. Fast forward 20 years and 183 ‘Best of’ editions across 60 countries, Sven now lives in Tampa, Florida with his wife and young son. He is working on disrupting the publishing business by mapping out the Innovation ecosystems of every major city in the U.S. and around the world, through his latest Innovation books and augmented reality video series.
Shane Senior has over 20 years of investment banking experience, with 15 of those years cultivating industry relationships with investors and strategic executives within pharma services.
Prior to co-founding Crosstree Capital Partners, Senior established the corporate finance practice at William R. Hough & Co. (later acquired by the Royal Bank of Canada) and spent six years providing M&A investment banking services with Citigroup.
Senior has advised more than 150 companies and has managed or participated in more than 90 successful transactions. Senior is a CFA charterholder, member of the Chartered Financial Analyst Institute, and a member of the Drug Industry Association (DIA).
CRO Advisors LLC services include strategy assessment and development, organizational evaluation and design, acquisition targeting and due diligence, bidding, pricing and negotiation support, post-merger integration management, team building, restructuring support, process improvement, governance support for owners and operators, senior leader coaching and interim management services.
Sullivan was President and CEO of Harlan Laboratories, a major pre-clinical CRO from 2006-2010. From 1999-2006 he headed most of the clinical divisions of Covance, Inc. Prior to Covance, Sullivan was Chairman, President and Chief Executive Officer of Xenometrix, Inc., a drug discovery tool company. Previously, he served in several senior management positions at Abbott Laboratories, including Vice President of Worldwide Marketing for Abbott Diagnostics, and Vice President and General Manager of the Diagnostic Assay Sector and also held senior management positions at Lyphomed, Inc., Dart and Kraft Inc., and Baxter International.
Sullivan has served on several public, private and not-for-profit boards and is currently Chairman of Interpace Diagnostics, Inc. (NASDAQ:IDXG), a molecular diagnostics lab, Chairman of MI Bioresearch, Inc., a venture-backed oncology discovery services company, Chairman of Analytical Lab Group LLC, comprised of three microbiology service companies, and Board Member of TransnetYX, Inc., the leader in genotyping of research models in drug development.
Recent exits/boards include Firma Clinical Research where Steve was Chairman for three years sold to Northlane Capital, PHT Corporation sold to eResearch, MediMedia Pharma Services to Icon. PLC, PDI contract sales to Publicis and BioreclamationIVT to Arsenal Capital.
Steve was an infantry company commander in the U. S. Marine Corps and received his MBA from Rutgers University and B.S. from the University of Dayton. Academic experience includes 14 years as an Adjunct Professor of International Business, Policy and Strategy, and Leadership at the Kellogg Graduate School of Management Northwestern University from 1983-1997.
In 2016, Steve created and regularly teaches “Drug Development from Discovery to Post-approval” at Georgetown University, School of Biotechnology, Georgetown University Medical Center where he is an Adjunct Professor.
Mr. Richard F. Cimino is an independent consultant who focuses on growth equity in the Health Services sector. Mr. Cimino has served on several boards. Currently he is the Executive Chairman of TwoLabs Inc. and a Director of Evolution Research Group. Previously, Mr. Cimino was non-Executive Chairman of the Board of MedAvante Inc., a privately held pharma services sector company. Mr. Ciminos’ primary responsibilities as Chairman included; governance, strategy, succession planning and key initiative planning and implementation. Mr. Cimino also served as an independent director for BioClinca Inc. (NASDAQ: BIOC) for six years.
Mr. Cimino is a seasoned executive in the Pharma Services sector where he served as Executive Vice President and Group President Clinical Development and Commercialization Services at Covance, Inc. Mr. Cimino oversaw global operations in 60+ countries for; Clinical Pharmacology, Early Clinical Development, Phase II/IV Clinical Development, Commercialization Services as well as Covance’s Molecule Development Group. He was a member of the company’s Operating Committee, Executive Committee and Benefits Committee. Mr. Cimino also directed corporate strategy and reported directly to the Chairman and Chief Executive Officer.
Additionally, Mr. Cimino held several senior management positions during a 20-year career at Eastman Kodak. Most notably, he served as Corporate Vice President, Health Imaging Group, where he was instrumental in the digital transformation of Kodak’s second-largest business, now Carestream Health Inc. Mr. Cimino holds a Bachelor of Science degree in biology from the State University of New York at Geneseo.
Richard J. Riegel leads LMC Advisory, LLC, which was established to provide advisory and consulting services for investors and organizations that are focused on high growth solutions opportunities in life sciences. Services provided and experiences include market assessment, buy-side advisory, board membership, and mentoring and advising company leadership teams on strategy, go-to-market and building equity value.
He is a CEO with a proven track record of successfully transforming solutions companies to higher growth, greater profitability and increased shareholder value. He serves as the vice chairman of the board of Phlexglobal, Inc. and he previously served as the company’s Chief Executive Officer before his retirement in early 2019. Phlexglobal provides specialized technology and expert services solutions for the pharmaceutical and life sciences industry across the Trial Master File, Clinical and Regulatory processes. Under his four years of leadership, Phlexglobal grew significantly, improved profitability, established a significant services operation in Poland, and he led the sale process to new private equity ownership. He also serves on the Board of Advisors of Gens & Associates and Adaptive Clinical.
Previously, as CEO of LIQUENT, he managed the divestiture of LIQUENT out of Thomson Reuters to private equity ownership, and after transforming the company to higher growth and profitability, led the sale of LIQUENT to PAREXEL, a leading Clinical Research Organization.
Throughout his 30-plus year career, Riegel has held key positions with increasing responsibilities in the technology and professional services industries as a CEO, vice president, general manager, and head of sales, supporting companies in the pharmaceutical and life sciences industries including IBM, First Consulting Group, Taratec Development and Barnett International.
Riegel earned a Master of Business Administration degree from Villanova University and a Bachelor of Science degree in Mechanical Engineering from Penn State. He lives in West Chester, Pennsylvania, with his wife, Tracy. They have three grown daughters.
Become part of the innovation ecosystem by nominating the
innovators and companies that deserve to be featured.
The experts, thought leaders and academics with the ideas
The innovators, the entrepreneurs, and the startups
The supporters, funders, and enablers of innovation for the ecosystem